我是 LongbridgeAI，我可以总结文章信息。道琼斯的头条新闻包括特斯拉第二季度销量激增和一名司机被控过失杀人。谷歌在欧盟的安卓罚款诉讼中败诉，而 Blue Owl 的投资者请求提取 47 亿美元。SAP 计划削减成本以进行人工智能投资，Quantum Systems 以 80 亿美元的估值筹集了 12 亿美元。National Beverage 的股票因特别股息上涨，Yara 收购了一家德克萨斯州的氨气工厂，香奈儿收购了 Charvet。罗氏的肺癌药物在试验中显示出希望
Tesla Sales Jumped in Second Quarter
The electric automaker sells just three new-car models now, with CEO Elon Musk putting the focus on autonomous vehicles and robotics.
----
Google Loses Fight Against EU's $4.7 Billion Android Fine
The penalty is the largest the EU has handed the company in its efforts to curb Google's online dominance.
----
Blue Owl Investors Ask to Withdraw $4.7 Billion From Flagship Funds
Redemption requests declined from the previous quarter but remained elevated.
----
Tesla Driver Charged With Manslaughter After Crashing Into Texas Home, Killing Woman
Investigators say the driver acted to override the car's automated driving assistance system.
----
SAP Seeks to Rein In Costs to Focus on AI Investments
SAP said it would exercise greater discipline when it comes to hiring and travel expenses as it seeks to redeploy workers in roles where they can make better use of AI.
----
German Drone Maker Quantum Systems Raises Funding at $8 Billion Valuation
Quantum Systems said it had raised $1.2 billion at a valuation of roughly $8 billion, bringing in fresh capital to expand drone production and invest in software for autonomous systems powered by artificial intelligence.
----
Starlink Dominates Internet From Space. Can It Disrupt AT&T and Verizon on the Ground?
SpaceX wants its satellite network to eventually serve cellphones in dense urban areas, but capacity and infrastructure hurdles remain.
----
National Beverage Stock Jumps After LaCroix Owner Declares Special Dividend
National Beverage, the maker of LaCroix sparkling water, announced its 13th special dividend in 22 years, sending shares sharply higher despite mixed annual results.
----
Why Medicare Isn't a Game Changer for Weight-Loss Drugmakers
Medicare is now covering weight-loss drugs for some seniors, in a win for patients. For Wall Street, the math is trickier.
----
Norway's Yara to Buy Texas Ammonia Plant For $1.3 Billion
The addition of U.S. production capacity supports the fertilizer producer's strategy of diversifying energy exposure, capturing economies of scale, and lowering fixed costs.
----
Chanel Snaps Up Storied French Shirtmaker Charvet
It is a rare acquisition for the fashion house as it looks to further widen its offer beyond its famed luxury handbags.
----
Consumers Shun Mid-Sized Packs Amid Price Squeeze, Nestle Says
The company is working to keep prices in check, as U.S. consumers fixate on affordability and buyers shift toward bulk or budget pack sizes, passing over middle formats.
----
Brightline Buys Time as Bankruptcy Loan Talks Continue
After extending its interest payment deadline and securing a small financing, Brightline secures two more weeks to negotiate with lenders.
----
KKR and Energy Capital Partners Look to Bet on DCC's Industry Pivot
The private-equity firms aim to gain from the multi-industry conglomerate's recent pivot to focus on its energy businesses, analysts say
----
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Experimental drug, divarasib, showed meaningful improvements in both patients' overall survival and the time they survived without the disease worsening.
(END) Dow Jones Newswires
July 02, 2026 17:15 ET (21:15 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.